IMURAN (azathioprine sodium) · CASPER PHARMA LLC
IMURAN is FDA-approved to treat 1 condition (same as AZATHIOPRINE SODIUM).
Details
- Status
- Discontinued
- First Approved
- 1968-03-20
- Routes
- INJECTION, ORAL
- Dosage Forms
- INJECTABLE, TABLET
IMURAN Approval History
What IMURAN Treats
1 indicationsIMURAN is approved for 1 conditions since its original approval in 1968. These indications span multiple therapeutic areas including oncology, immunology, and more.
Same approved indications as AZATHIOPRINE SODIUM (same active ingredient).
Clinical Trial Registry
2 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT02081755 | 013-307 | Ph 4 | enrolling by invitation | Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer |
| NCT05646992 OPRTUNTI | IRB00166167 | Ph 2, Ph 3 | recruiting | Uterus Transplantation to Treat Infertility |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
IMURAN FDA Label Details
Indications & Usage
FDA Label (PDF)IMURAN is FDA-approved to treat 1 condition — same approved indications as AZATHIOPRINE SODIUM.
Track IMURAN with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.